Health Encyclopedia

Chronic lymphocytic leukemia (CLL)

Definition

Chronic lymphocytic leukemia is cancer of the white blood cells (lymphocytes).

Alternative Names

CLL; Leukemia - chronic lymphocytic (CLL)

Causes, incidence, and risk factors

Chronic lymphocytic leukemia (CLL) causes a slow increase in the number of B lymphocytes in the bone marrow. The cancerous cells spread from the blood marrow to the blood, and can also affect the lymph nodes and other organs. CLL causes the bone marrow to fail and weakens the immune system.

The reason for this increase in B lymphocytes is unknown. There is no link to radiation, cancer-causing chemicals, or viruses.

Usually, the symptoms develop gradually. Many cases are detected by routine blood tests in people with no symptoms.

CLL primarily strikes adults. The average age of a patient with this type of leukemia is 70. It is rarely seen in people younger than 40. The disease is more common in Jewish people of Russian or East European descent, and is uncommon in Asia.

Symptoms

Enlarged lymph nodes, liver, or spleen
Fatigue
Abnormal bruising (occurs late in the disease)
Excessive sweating, night sweats
Loss of appetite
Unintentional weight loss

Signs and tests

Patients with CLL have a higher-than-normal white blood cell count.

Tests to diagnose CLL include:

CBC
Flow cytometry
Bone marrow aspiration
Serum protein electrophoresis

If your doctor discovers you have CLL, tests will be done to see how much the cancer has spread. This is called staging. There are two methods to stage CLL.

There are different ways to stage CLL. One system uses numbers to group CLL into low-, intermediate-, and high-risk categories. Generally, the higher the stage number, the more advanced the cancer. Another system uses letters to stage CLL according to how many lymph node groups are affected and whether or not you have a drop in red blood cells and platelets.

Treatment

Early stage disease often requires no specific treatment, but it is important to be closely monitored by your doctor.

Chemotherapy may be needed if fatigue, anemia, thrombocytopenia, or lymph node swelling occurs. Several chemotherapy drugs are commonly used to treat CLL. A common drug used is chlorambucil (Leukeran). Fludarabine and cyclophosphamide (Cytoxan) may also be used.

Rituximab (Rituxan), may also be used alone or in combination with traditional chemotherapy. Alemtuzumab (Campath) is approved for treatment of patients with CLL that have not responded to fludarabine.

Rarely, radiation may be used for enlarged lymph nodes. Blood transfusions or platelet transfusions may be required. Stem cell transplantation may be used in advances stages of CLL.

Support Groups

The stress of illness may be eased by joining a support group whose members share common experiences and problems.

Expectations (prognosis)

The outlook depends on the stage of the disease. Half of patients diagnosed in the earliest stages of the disease live more than 12 years. Several new tests that look at cell and genetic changes can help predict life expectancy.

Complications

Hypogammaglobulinemia (reduced levels of antibodies) -- increases the risk of infection
Other cancer
Side effects of chemotherapy
Bleeding from low platelets
Fatigue from anemia
Autoimmune hemolytic anemia
Idiopathic thrombocytopenic purpura (ITP)

Calling your health care provider

Call health care provider if you develop enlarged lymph nodes or unexplained fatigue, bruising, excessive sweating, or weight loss.

References

American Cancer Society. Cancer Facts and Figures 2006. Atlanta, Ga: American Cancer Society; 2006.

Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKena WG. Clinical Oncology. 3rd ed. Orlando, Fl: Churchill Livingstone; 2004:2921-2940.

Review Date:9/11/2006
Reviewed By:Corey Cutler, MD, MPH, FRCP(C), Assistant Professor of Medicine, Harvard Medical School; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Review provided by VeriMed Healthcare Network.

ADAM Quality A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.